Phreesia, Inc. (NYSE:PHR - Get Free Report) insider Janet Gunzburg sold 1,709 shares of the stock in a transaction dated Monday, April 8th. The stock was sold at an average price of $22.62, for a total transaction of $38,657.58. Following the completion of the sale, the insider now directly owns 38,900 shares in the company, valued at $879,918. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Janet Gunzburg also recently made the following trade(s):
- On Tuesday, March 19th, Janet Gunzburg sold 2,817 shares of Phreesia stock. The stock was sold at an average price of $23.27, for a total transaction of $65,551.59.
- On Friday, February 9th, Janet Gunzburg sold 480 shares of Phreesia stock. The stock was sold at an average price of $28.00, for a total transaction of $13,440.00.
- On Thursday, February 1st, Janet Gunzburg sold 328 shares of Phreesia stock. The stock was sold at an average price of $25.99, for a total transaction of $8,524.72.
- On Friday, January 12th, Janet Gunzburg sold 205 shares of Phreesia stock. The stock was sold at an average price of $24.11, for a total transaction of $4,942.55.
Phreesia Stock Down 1.9 %
Shares of Phreesia stock opened at $23.29 on Thursday. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.78 and a current ratio of 1.78. Phreesia, Inc. has a 52-week low of $12.05 and a 52-week high of $34.98. The stock has a market capitalization of $1.31 billion, a price-to-earnings ratio of -9.24 and a beta of 0.92. The company's 50 day moving average price is $24.81 and its 200-day moving average price is $21.07.
The Gold Grab of the Century
From Colonial Metals | Ad
When central banks buy gold…
The rich buy right along with them.
And central banks are buying at breakneck pace.
Last year… 1,037 tons.
Just 45 tons less than the record set two years ago.
That's why we have released our Free Precious Metals Investment Guide.
Phreesia (NYSE:PHR - Get Free Report) last issued its earnings results on Thursday, March 14th. The company reported ($0.56) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.58) by $0.02. Phreesia had a negative net margin of 38.42% and a negative return on equity of 53.33%. The firm had revenue of $95.00 million for the quarter, compared to analysts' expectations of $93.52 million. During the same quarter last year, the business earned ($0.72) earnings per share. The business's revenue was up 24.0% on a year-over-year basis. Equities research analysts forecast that Phreesia, Inc. will post -1.48 EPS for the current year.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the company. Acadian Asset Management LLC purchased a new stake in Phreesia in the first quarter worth $43,000. Captrust Financial Advisors lifted its stake in Phreesia by 154.6% in the second quarter. Captrust Financial Advisors now owns 1,426 shares of the company's stock worth $36,000 after acquiring an additional 866 shares during the period. International Assets Investment Management LLC lifted its stake in Phreesia by 1,987.3% in the fourth quarter. International Assets Investment Management LLC now owns 1,482 shares of the company's stock worth $34,000 after acquiring an additional 1,411 shares during the period. State of Wyoming lifted its stake in Phreesia by 34.6% in the second quarter. State of Wyoming now owns 1,918 shares of the company's stock worth $59,000 after acquiring an additional 493 shares during the period. Finally, Tower Research Capital LLC TRC lifted its stake in Phreesia by 85.4% in the third quarter. Tower Research Capital LLC TRC now owns 3,137 shares of the company's stock worth $80,000 after acquiring an additional 1,445 shares during the period. Institutional investors own 92.10% of the company's stock.
Wall Street Analysts Forecast Growth
PHR has been the topic of several research analyst reports. JMP Securities upped their price objective on shares of Phreesia from $28.00 to $30.00 and gave the stock a "market outperform" rating in a research report on Thursday, March 21st. Truist Financial initiated coverage on shares of Phreesia in a research report on Monday, February 26th. They issued a "buy" rating and a $35.00 price objective on the stock. Raymond James restated an "outperform" rating and issued a $30.00 price objective (up from $25.00) on shares of Phreesia in a research report on Friday, March 15th. Robert W. Baird increased their price target on shares of Phreesia from $30.00 to $31.00 and gave the company an "outperform" rating in a research report on Monday, March 18th. Finally, Barclays initiated coverage on shares of Phreesia in a research report on Wednesday, January 3rd. They set an "overweight" rating and a $29.00 price target on the stock. Two analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $31.62.
Get Our Latest Report on PHR
Phreesia Company Profile
(
Get Free Report)
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
